These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 29567579)
1. Palliative shunt surgery for patients with leptomeningeal metastasis. Murakami Y; Ichikawa M; Bakhit M; Jinguji S; Sato T; Fujii M; Sakuma J; Saito K Clin Neurol Neurosurg; 2018 May; 168():175-178. PubMed ID: 29567579 [TBL] [Abstract][Full Text] [Related]
2. Clinical outcome of cerebrospinal fluid shunts in patients with leptomeningeal carcinomatosis. Kim HS; Park JB; Gwak HS; Kwon JW; Shin SH; Yoo H World J Surg Oncol; 2019 Mar; 17(1):59. PubMed ID: 30917830 [TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid diversion and outcomes for lung cancer patients with leptomeningeal carcinomatosis. Su YH; Chiang CL; Yang HC; Hu YS; Chen YW; Luo YH; Chen CJ; Wu HM; Lin CJ; Lee CC Acta Neurochir (Wien); 2022 Feb; 164(2):459-467. PubMed ID: 33646444 [TBL] [Abstract][Full Text] [Related]
4. Palliative lumboperitoneal shunt for leptomeningeal metastasis-related hydrocephalus: A case series. Yamashiro S; Hitoshi Y; Tajiri S; Uchikawa H; Ito K; Yoshida A; Kuratsu JI Palliat Med; 2017 Jan; 31(1):93-96. PubMed ID: 27188875 [TBL] [Abstract][Full Text] [Related]
5. Palliative cerebrospinal fluid shunting for leptomeningeal metastasis-related hydrocephalus in patients with lung adenocarcinoma: A single-center retrospective study. Mitsuya K; Nakasu Y; Hayashi N; Deguchi S; Takahashi T; Murakami H; Naito T; Kenmotsu H; Ono A; Wakuda K; Harada H PLoS One; 2019; 14(1):e0210074. PubMed ID: 30629621 [TBL] [Abstract][Full Text] [Related]
6. Ventriculoperitoneal shunt for hydrocephalus caused by central nervous system metastasis. Lee SH; Kong DS; Seol HJ; Nam DH; Lee JI J Neurooncol; 2011 Sep; 104(2):545-51. PubMed ID: 21274592 [TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of surgically treated hydrocephalus in leptomeningeal metastases. Jung TY; Chung WK; Oh IJ Clin Neurol Neurosurg; 2014 Apr; 119():80-3. PubMed ID: 24635931 [TBL] [Abstract][Full Text] [Related]
8. Postoperative course of cerebrospinal fluid diversion in the setting of leptomeningeal disease: a systematic review, meta-analysis, and meta-regression with an illustrative case. Lu VM; Abou-Al-Shaar H; Bin-Alamer O; Luther EM; Benjamin CG J Neurooncol; 2023 May; 163(1):29-37. PubMed ID: 37191912 [TBL] [Abstract][Full Text] [Related]
10. One-year outcome in patients with idiopathic normal-pressure hydrocephalus: comparison of lumboperitoneal shunt to ventriculoperitoneal shunt. Miyajima M; Kazui H; Mori E; Ishikawa M; J Neurosurg; 2016 Dec; 125(6):1483-1492. PubMed ID: 26871203 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Palliative Cerebrospinal Fluid Shunting for Patients With Leptomeningeal Carcinomatosis-related Hydrocephalus. Yoshioka H; Okuda T; Nakao T; Fujita M; Takahashi JC Anticancer Res; 2021 Aug; 41(8):4169-4172. PubMed ID: 34281889 [TBL] [Abstract][Full Text] [Related]
12. Lumboperitoneal shunt for the treatment of leptomeningeal metastasis. Zhang XH; Wang XG; Piao YZ; Wang P; Li P; Li WL Med Hypotheses; 2015 May; 84(5):506-8. PubMed ID: 25754849 [TBL] [Abstract][Full Text] [Related]
14. Identifying the Preoperative Radiological Risk Features in Patients with Leptomeningeal Carcinomatosis Undergoing Cerebrospinal Fluid Drainage. Hou Q; Mo Y; Guo J; Deng T; Mo L; Wei C World Neurosurg; 2024 Jun; 186():e614-e621. PubMed ID: 38593911 [TBL] [Abstract][Full Text] [Related]
15. Challenges in cerebrospinal fluid shunting in patients with glioblastoma. Hong B; Polemikos M; Heissler HE; Hartmann C; Nakamura M; Krauss JK Fluids Barriers CNS; 2018 Jun; 15(1):16. PubMed ID: 29860942 [TBL] [Abstract][Full Text] [Related]
16. What is the risk of a shunt malfunction after elective intradural surgery? Venable GT; Green CS; Smalley ZS; Bedford EC; Modica JS; Klimo P J Neurosurg Pediatr; 2015 Dec; 16(6):642-7. PubMed ID: 26359674 [TBL] [Abstract][Full Text] [Related]
17. [A case of lumboperitoneal shunt as an effective palliative tool in a patient with leptomeningeal metastasis]. Yamashiro S; Yoshida AO; Tajiri S; Anal S; Ito K; Kuratsu J No Shinkei Geka; 2009 Oct; 37(10):1007-11. PubMed ID: 19882962 [TBL] [Abstract][Full Text] [Related]
18. Obstructive hydrocephalus in adult patients: the Louisiana State University Health Sciences Center-Shreveport experience with ventriculoperitoneal shunts. Reddy GK; Shi R; Nanda A; Guthikonda B World Neurosurg; 2011; 76(1-2):176-82. PubMed ID: 21839971 [TBL] [Abstract][Full Text] [Related]
19. Benefit of ventriculoperitoneal cerebrospinal fluid shunting and intrathecal chemotherapy in neoplastic meningitis: a retrospective, case-controlled study. Lin N; Dunn IF; Glantz M; Allison DL; Jensen R; Johnson MD; Friedlander RM; Kesari S J Neurosurg; 2011 Oct; 115(4):730-6. PubMed ID: 21721878 [TBL] [Abstract][Full Text] [Related]
20. [Multidisciplinary treatment of leptomeningeal metastasis in patients with lung adenocarcinoma: the triple modality combination of EGFR-TKI, VP shunt and irradiation]. Mitsuya K; Nakasu Y; Mizokami Y; Takahashi T; Nakamura Y; Ono A; Toda Y; Yamamoto N; Harada H; Nishimura T No Shinkei Geka; 2012 Jun; 40(6):503-9. PubMed ID: 22647509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]